Shasun Pharmaceuticals shares surge over 7% on completion of regulatory inspection
Shares of Shasun Pharmaceuticals surged in trade today after the company announced that it successfully completed the USFDA inspection.
By ET Online | Updated:
MUMBAI: Shares of Shasun Pharmaceuticals surged in trade today after the company announced that it successfully completed the USFDA inspection during the first week of June 2013.
At 11:45 a.m.; the stock was at Rs 77.25, up 7.29 per cent, on the BSE. It touched a high of Rs 79.50 and a low of Rs 72.60 in trade today.
On the completion of the inspection, the USFDA officials concluded that the facility, systems and practices comply with the requirements and there were no recommendations or observations.
The company also underwent a Brazilian ANVISA inspection in the first week of July 2013. This is a pre-approval inspection for an NDA product with a pharmaceutical company associated with Shasun.
At 11:45 a.m.; the stock was at Rs 77.25, up 7.29 per cent, on the BSE. It touched a high of Rs 79.50 and a low of Rs 72.60 in trade today.
On the completion of the inspection, the USFDA officials concluded that the facility, systems and practices comply with the requirements and there were no recommendations or observations.
The company also underwent a Brazilian ANVISA inspection in the first week of July 2013. This is a pre-approval inspection for an NDA product with a pharmaceutical company associated with Shasun.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Shasun Pharmaceuticals seeks shareholder nod for merger with Strides ArcolabADVERTISEMENT
